Company / Tangible Book Value per Share
MoonLake Immunotherapeutics Tangible Book Value per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$4.72
FY2025
5-year range
-$1.49 / $10.45
FY2021-FY2025
Trend
-33.5%
vs FY2024
Sector context
#100 of 209
Health Care
What the data says
At $4.72, MoonLake Immunotherapeutics's tangible book value per share ranks #100 of 209 in the Health Care sector. Declined from $10.45 to $4.72 over the past 2 years.
Based on SEC 10-K filings.
4.72 in FY2025 with a 3-year CAGR of +26.3%.
Declined from $10.45 to $4.72 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +26.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#100 of 209 in Health CareTop 48% of 209This company $4.72 Sector average $93.47
▼
-94.9% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 33.5% year-over-year.
- Ranks #100 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2023.
- Lowest tangible book value per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.72 | -33.5% |
| FY2024 | $7.11 | -32.0% |
| FY2023 | $10.45 | +346.3% |
| FY2022 | $2.34 | +257.7% |
| FY2021 | -$1.49 | -267.8% |
| FY2020 | -$0.40 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026